# DMT310-003 Topical in the Treatment of Acne Vulgaris

> **NCT04106778** · PHASE2 · COMPLETED · sponsor: **Dermata Therapeutics** · enrollment: 181 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** DMT310
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04106778
- **Lead sponsor:** Dermata Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-10
- **Primary completion:** 2020-05-04
- **Final completion:** 2020-05-04
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04106778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04106778, "DMT310-003 Topical in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04106778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*